Genetic Technologies Ltd (NASDAQ:GENE)

Tuesday’s Trading Day
5.36 -0.37 / -6.46%
As of Mar 03
Day’s Change
Wednesday’s Pre-Market   Switch to standard view »
5.30 -0.06 / -1.12%
Volume: 3.5K
Institutional investors purchased a net $40.6 thousand shares of GENE during the quarter ended June 2014. This may signal that the smart money is gaining interest in this company as the 1.41% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Other institutional1.29%
Mutual fund holders0.12%
Individual stakeholders--

Largest Quarterly Institutional

Latest Institutional Activity

12/31/2014RENAISSANCE TECHNOLOGIES LLC  Bought 37.0 Thousand shares of Genetic Technologies Ltd
12/31/2014THOMPSON DAVIS & CO., INC.  Bought 13.8 Thousand shares of Genetic Technologies Ltd
12/31/2014COLUMBIA MANAGEMENT INVESTMENT A...  Bought 1.7 Thousand shares of Genetic Technologies Ltd

Top 10 Owners of Genetic Technologies Ltd

Total value ($)Shares
bought / sold
Renaissance Technologies LLC0.91%58,800164,052+37,040+170.22%
Thompson Davis & Co., Inc.0.21%13,80038,502+13,800--
PEH Wertpapier AG (Germany)0.12%7,47220,847+7,472--
Columbia Management Investment Ad...0.07%4,58212,784+1,652+56.38%
KCG Americas LLC0.06%3,93910,990-10,810-73.29%
Alpine Securities USVI LLC0.03%2,2206,19400.00%
Morgan Stanley & Co. LLC0.00%411+1+33.33%
Citadel Advisors LLC0.00%00-2,955-100.00%
Jane Street Capital LLC0.00%00-2,943-100.00%
A.R.T. Advisors LLC0.00%00-2,620-100.00%

Top 10 Mutual Funds Holding Genetic Technologies Ltd

Mutual fundStakeShares
Total value ($)Shares
bought / sold
Almax Capital - Event Driven Fund0.12%7,47220,847+7,472--

To view my watchlist

Not a member yet?

Sign up now for a free account